BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26898681)

  • 1. Risk-reduction surgery in pediatric surgical oncology: A perspective.
    Sandoval JA; Fernandez-Pineda I; Malkan AD
    J Pediatr Surg; 2016 Apr; 51(4):675-87. PubMed ID: 26898681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
    Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
    J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC): a review of clinical, genetic and therapeutic aspects.
    Soravia C; Bapat B; Cohen Z
    Schweiz Med Wochenschr; 1997 Apr; 127(16):682-90. PubMed ID: 9140167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive surgery for colon cancer in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer syndrome.
    Möslein G; Pistorius S; Saeger HD; Schackert HK
    Langenbecks Arch Surg; 2003 Mar; 388(1):9-16. PubMed ID: 12690475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics and management strategies in hereditary cancer syndromes.
    Hanna NN; Mentzer RM
    J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer.
    Church JM
    Ann Med; 1996 Dec; 28(6):479-82. PubMed ID: 9017106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-cadherin mutations and hereditary gastric cancer: prevention by resection?
    Fitzgerald RC; Caldas C
    Dig Dis; 2002; 20(1):23-31. PubMed ID: 12145417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes.
    Peacock O; Waters PS; Otero de Pablos J; Boussioutas A; Skandarajah A; Simpson JA; Warrier SK; Heriot AG
    Eur J Surg Oncol; 2019 Dec; 45(12):2241-2250. PubMed ID: 31262600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic thyroidectomy: who needs it, when, and why.
    Wang TS; Opoku-Boateng A; Roman SA; Sosa JA
    J Surg Oncol; 2015 Jan; 111(1):61-5. PubMed ID: 24965542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited cancer syndromes and the thyroid: an update.
    Metzger R; Milas M
    Curr Opin Oncol; 2014 Jan; 26(1):51-61. PubMed ID: 24300902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation immunohistochemistry: Emerging substitutes to genetic testing?
    Andrici J; Gill AJ; Hornick JL
    Semin Diagn Pathol; 2018 May; 35(3):161-169. PubMed ID: 28662997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
    van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
    Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hereditary intestinal polyposis syndromes.
    Dean PA
    Rev Gastroenterol Mex; 1996; 61(2):100-11. PubMed ID: 8927912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic predisposition to colorectal cancer: new pieces in the pediatric puzzle.
    Durno CA; Gallinger S
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):5-15. PubMed ID: 16819371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality-of-life implications of risk-reducing cancer surgery.
    Altman AM; Hui JYC; Tuttle TM
    Br J Surg; 2018 Jan; 105(2):e121-e130. PubMed ID: 29341149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic Surgery and Extended Oncologic Radicality in Gastric and Colorectal Hereditary Cancer Syndromes.
    Vogelsang HE
    Visc Med; 2019 Aug; 35(4):231-239. PubMed ID: 31602384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of prophylactic surgical treatment for familial adenomatous polyposis in Japan.
    Yamadera M; Ueno H; Kobayashi H; Konishi T; Ishida F; Yamaguchi T; Hinoi T; Inoue Y; Kanemitsu Y; Tomita N; Ishida H; Sugihara K
    Surg Today; 2017 Jun; 47(6):690-696. PubMed ID: 27770209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
    Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
    J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.